高同型半胱氨酸促进肾脏疾病的发生与发展
周云枫1, 管又飞2,*
1深圳大学医学部医学中心,基础医学院生理系,深圳 518060;2大连医科大学医学科学研究院,大连 116044
摘要
同型半胱氨酸是蛋氨酸代谢的中间产物,其代谢异常导致血中同型半胱氨酸浓度高于16 μmol/L,称为高同型半胱氨酸血症。目前研究表明,高同型半胱氨酸血症不仅与心脑血管疾病、外周血管病变、神经系统退行性疾病、糖尿病、妊娠高血压综合征、肝硬化等疾病的发病密切相关,而且在肾脏疾病的发生、发展过程中发挥重要作用。本文将就高同型半胱氨酸血症与肾脏疾病的关系作一综述,进一步明确其在肾脏疾病发生和发展中的重要性,将可能为肾脏疾病的防治提供新的线索。
分类号:R333.6
Hyperhomocysteinemia and kidney diseases
ZHOU Yun-Feng1, GUAN You-Fei2,*
1Medical Research Center, Physiology Department of Basic Medical College, Shenzhen University Health Science Center, Shenzhen 518060, China;2Advanced Institute of Medical Sciences, Dalian Medical University, Dalian 116044, China
Abstract
Homocysteine (Hcy) is an intermediate metabolite of methionine metabolism. Hyperhomocysteinemia (HHcy) is defined as a condition characterized by plasma Hcy level above 16 μmol/L which can result from abnormal Hcy metabolism. HHcy has been confirmed to be related to cardio-cerebrovascular disease, peripheral vascular disorders, neurodegenerative diseases, diabetes, pregnancy-induced hypertension syndrome, liver cirrhosis and kidney diseases. In this review, we summarize the correlation between HHcy and kidney diseases. Elucidating the role of HHcy in kidney diseases may provide a new strategy to prevent and treat kidney diseases.
Key words: Homocysteine; hyperhomocysteinemia; kidney diseases
收稿日期:2018-08-09 录用日期:2018-11-12
通讯作者:管又飞 E-mail: guanyf@dmu.edu.cn
DOI: 10.13294/j.aps.2018.0087
引用本文:
周云枫, 管又飞. 高同型半胱氨酸促进肾脏疾病的发生与发展[J]. 生理学报 2018; 70 (6): 607-611.
ZHOU Yun-Feng, GUAN You-Fei. Hyperhomocysteinemia and kidney diseases. Acta Physiol Sin 2018; 70 (6): 607-611 (in Chinese with English abstract).